Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:05 pm Purchase | 2025-09-30 | 13G | CASI Pharmaceuticals, Inc. CASI | Foresite Capital Fund VI LP | 979,956 6.300% | 192,835 (+24.50%) | Filing History |
| 2025-10-23 7:09 pm Purchase | 2025-10-16 | 13G | Verastem, Inc. VSTM | Foresite Capital Fund VI LP | 3,135,120 5.100% | 3,135,120 (New Position) | Filing History |
| 2025-08-12 4:05 pm Sale | 2025-06-30 | 13G | CASI Pharmaceuticals, Inc. CASI | Foresite Capital Fund VI LP | 787,121 5.100% | -522,262 (-39.89%) | Filing History |
| 2025-06-10 4:37 pm Unchanged | 2025-05-21 | 13D | Alumis Inc. Common Stock ALMS | Foresite Capital Fund VI LP | 15,197,954 15.900% | 0 (Unchanged) | Filing History |
| 2025-05-07 3:33 pm Purchase | 2024-08-13 | 13D | Alumis Inc. Common Stock ALMS | Foresite Capital Fund VI LP | 15,197,954 32.200% | 15,197,954 (New Position) | Filing History |
| 2025-02-14 2:25 pm Sale | 2024-09-30 | 13G | enGene Holdings Inc. ENGN | Foresite Capital Fund VI LP | 0 0.000% | -2,500,000 (Position Closed) | Filing History |
| 2024-12-30 3:32 pm Purchase | 2024-12-23 | 13G | RAPT Therapeutics, Inc. RAPT | Foresite Capital Fund VI LP | 1,562,500 9.300% | 1,562,500 (New Position) | Filing History |
| 2024-07-05 9:30 pm Purchase | 2024-06-27 | 13D | Alumis Inc. Common Stock ALMS | Foresite Capital Fund VI LP | 15,152,954 29.200% | 15,152,954 (New Position) | Filing |
| 2024-06-20 9:00 pm Purchase | 2024-06-10 | 13G | CASI Pharmaceuticals, Inc. CASI | Foresite Capital Fund VI LP | 1,309,383 9.800% | 1,309,383 (New Position) | Filing History |
| 2024-02-23 1:32 pm Purchase | 2024-02-16 | 13G | enGene Holdings Inc. ENGN | Foresite Capital Fund VI LP | 2,500,000 5.800% | 2,500,000 (New Position) | Filing History |